SCHEMBL8286135

SCHEMBL8286135

Cc1ccc2c(=O)c(COc3ccccc3)c(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 1/20 0.46
MAPK8 P45983 6/20 0.44
MAPK9 P45984 5/20 0.44
MAPK10 P53779 5/20 0.44
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PKM P14618 1/20 0.39
GSK3B P49841 1/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
KMT2A Q03164 2/20 0.38
USP2 O75604 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286133 0.89 MAT2A (0.50) MAT2AMAPK8MAPK9MAPK10NPC1
SCHEMBL8286138 0.88 MAT2A (0.43) MAT2AMAPK8MAPK9MAPK10NPC1
SCHEMBL8287392 0.85 MAPK8 (0.47) MAT2AMAPK8MAPK9MAPK10NPC1
SCHEMBL8286136 0.83 MAPK8 (0.46) MAT2AMAPK8MAPK9MAPK10NPC1
SCHEMBL8286126 0.83 MAPK8 (0.46) MAT2AMAPK8MAPK9MAPK10NPC1
SCHEMBL8285234 0.83 MAT2A (0.47) MAT2AMAPK8MAPK9MAPK10SMN1; SMN2
SCHEMBL8286206 0.81 NPC1 (0.38) MAPK8NPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL8287156 0.80 MAT2A (0.50) MAT2AMAPK8MAPK9MAPK10SMN1; SMN2
SCHEMBL8285229 0.78 MAPK8 (0.50) MAT2AMAPK8MAPK9MAPK10SMN1; SMN2
SCHEMBL8287183 0.78 MAT2A (0.48) MAT2AMAPK8MAPK9MAPK10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed